Ramucirumab antibody | AbD53006ia
A microtiter plate was coated overnight with various antigens at a concentration of 5 μg/ml. After washing and blocking with PBST + 5% BSA, detection was performed using HRP conjugated Human Anti-Ramucirumab Antibody, clone AbD53006ia (HCA408) at a concentration of 2 μg/mL in HISPEC Assay Diluent (BUF049A) followed by QuantaBlu Fluorogenic Peroxidase Substrate. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit (LNK002P).
A microtiter plate was coated overnight with ramucirumab, VEGFR2-His, human IgG1 kappa control or NHS at a concentration of 5 µg/ml. After washing and blocking with PBST + 5% BSA, detection was performed using HRP conjugated Human Anti-Ramucirumab Antibody, clone AbD53006ia (HCA408) titrated to the given concentrations in HISPEC diluent (BUF049A) followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data for ramucirumab are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit (LNK002P).
A microtiter plate was coated overnight with VEGFR2-His at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, a pre-incubated mixture of ramucirumab (0.15 µg/ml) plus increasing concentrations of Human Anti-Ramucirumab Antibody, clone AbD53006ia (HCA408) in the monovalent Fab format was added. Free ramucirumab, still capable of binding to the VEGFR2-His coated plate was detected using HRP conjugated Mouse Anti-Human IgG (Fc) CH2 Domain Antibody (MCA647P) followed by QuantaBlu Fluorogenic Peroxidase Substrate. The non-inhibitory Human Anti-Ramucirumab Antibody, clone AbD53018ad (TZA052) was used as a negative control. Data are shown as the mean of three measurements.
A microtiter plate was coated overnight with ramucirumab at a concentration of 0.2 µg/ml. After washing and blocking with PBST + 5% BSA, PBST with 10% human serum was added spiked with increasing concentrations of Human Anti-Ramucirumab Antibody, clone AbD51672ia (HCA407, black), clone AbD53006ia (HCA408, blue) or clone AbD53014ia (HCA409, red). Detection was performed using HRP conjugated ramucirumab at a concentration of 2 µg/ml in HISPEC Assay Diluent (BUF049A) followed by QuantaBlu Fluorogenic Peroxidase Substrate. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit (LNK002P). Data are shown as the mean of three measurements.
Human anti Ramucirumab
- Product Type
- Monoclonal Antibody
- Clone
- AbD53006ia
- Isotype
- IgG1
- Specificity
- Ramucirumab
Antibody Quality and Performance Guarantee
HCA408
| Human Anti-Ramucirumab Antibody, clone AbD53006ia is a paratope specific, inhibitory, anti-idiotypic antibody (Type 1) that specifically recognizes the free human monoclonal antibody drug ramucirumab, and its biosimilar products. It does not recognize the drug target, the human vascular endothelial growth factor receptor 2 (VEGFR2), nor ramucirumab in complex with VEGFR2. This antibody can be used to measure free ramucirumab levels in serum from patients. HCA408 is a fully human recombinant monoclonal antibody with IgG1 isotype and is suitable as a surrogate positive control or calibrator in an anti-drug antibody (ADA) assay. This antibody has a monovalent intrinsic affinity of 0.8nM and is one of the three antibodies offered for ADA assays. Antibody HCA407 has an affinity of <0.1nM and HCA409 has an affinity of 1.4nM. Ramucirumab (trade name Cyramza) is a humanized monoclonal antibody of the IgG1/kappa isotype that binds to the extracellular VEGF-binding domain of VEGFR2 to prevent VEGF ligands to bind to VEGFR2. Ramucirumab therefore blocks the activation of VEGFR2 and the downstream angiogenesis pathways involved in tumor development and progression. Ramucirumab is indicated, alone or in combination with another drug for the treatment of advanced gastric adenocarcinoma and non-small cell lung cancer. |
- Product Form
- Human IgG1 antibody (lambda light chain) selected from the HuCAL phage display library and expressed in a human cell line. This product is supplied as a liquid.
- Preparation
- Purified IgG prepared by affinity chromatography on Protein A
- Source
- HKB-11
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.09% Sodium Azide (NaN3)
- Immunogen
- Ramucirumab
- Affinity
- The intrinsic affinity of the monovalent form of Human Anti-Ramucirumab Antibody, clone AbD53006ia is KD = 0.8 nM as measured by real time, label free molecular interaction analysis on immobilized ramucirumab
- Approx. Protein Concentrations
- Antibody concentration 0.5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
Cyramza is a trademark of Eli Lilly. - Licensed Use
- For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
This product is shipped refrigerated. When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA |  |
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
- Technical Advice
- Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual.
- ELISA
- Clone AbD53006ia can be used in indirect ELISA to detect ramucirumab. It can also be used as a surrogate positive control or a calibrator in an anti-drug antibody (ADA) assay, together with HCA407 and HCA409
- Synonyms
- Cyramza
HCA408
168739
If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
View more products with Ramucirumab specificity
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up